These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17618612)

  • 1. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis.
    Nishida M; Moriyama T; Ishii K; Takashima S; Yoshizaki K; Sugita Y; Yamauchi-Takihara K
    Clin Chim Acta; 2007 Sep; 384(1-2):99-104. PubMed ID: 17618612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.
    Sung SH; Chuang SY; Sheu WH; Lee WJ; Chou P; Chen CH
    Am J Cardiol; 2009 May; 103(10):1411-6. PubMed ID: 19427438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein is independently associated with arterial stiffness in women with metabolic syndrome.
    Oh EG; Kim SH; Bang SY; Hyun SS; Im JA; Lee JE; Yoo JY
    J Cardiovasc Nurs; 2012; 27(1):61-7. PubMed ID: 21372728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study.
    Saltevo J; Vanhala M; Kautiainen H; Kumpusalo E; Laakso M
    Diabet Med; 2008 Jun; 25(6):747-50. PubMed ID: 18435780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further inflammatory information on metabolic syndrome by adiponectin evaluation.
    Matsushita K; Tamakoshi K; Yatsuya H; Wada K; Otsuka R; Takefuji S; Hotta Y; Kondo T; Murohara T; Toyoshima H
    Int J Cardiol; 2008 Mar; 124(3):339-44. PubMed ID: 17433469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of waist circumference versus adiponectin level on subclinical atherosclerosis: a cross-sectional analysis in a sample from the general population.
    Holewijn S; den Heijer M; van Tits LJ; Swinkels DW; Stalenhoef AF; de Graaf J
    J Intern Med; 2010 Jun; 267(6):588-98. PubMed ID: 20210840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults.
    Ryu SY; Kim KS; Park J; Kang MG; Han MA
    J Prev Med Public Health; 2008 Nov; 41(6):413-8. PubMed ID: 19037171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes.
    Fukui M; Ose H; Kitagawa Y; Kamiuchi K; Nakayama I; Ohta M; Obayashi H; Yamasaki M; Hasegawa G; Yoshikawa T; Nakamura N
    Diabet Med; 2007 Aug; 24(8):864-71. PubMed ID: 17593243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein.
    Ahonen TM; Kautiainen HJ; Keinänen-Kiukaanniemi SM; Kumpusalo EA; Vanhala MJ
    Am J Prev Med; 2008 Dec; 35(6):598-601. PubMed ID: 18842390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-reactive protein and carotid intima-media thickness in a population of middle-aged Koreans].
    Suh M; Lee JY; Ahn SV; Kim HC; Suh I
    J Prev Med Public Health; 2009 Jan; 42(1):29-34. PubMed ID: 19229122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project.
    Ferreira I; Boreham CA; Twisk JW; Gallagher AM; Young IS; Murray LJ; Stehouwer CD
    J Hypertens; 2007 May; 25(5):1009-20. PubMed ID: 17414665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes.
    Tajiri Y; Mimura K; Umeda F
    Obes Res; 2005 Oct; 13(10):1810-6. PubMed ID: 16286529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin-6 and C-reactive protein with subclinical carotid atherosclerosis (the Rancho Bernardo Study).
    Lee WY; Allison MA; Kim DJ; Song CH; Barrett-Connor E
    Am J Cardiol; 2007 Jan; 99(1):99-102. PubMed ID: 17196470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness.
    Dullaart RP; Plomgaard P; de Vries R; Dahlbäck B; Nielsen LB
    Clin Chim Acta; 2009 Aug; 406(1-2):129-33. PubMed ID: 19539616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
    Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
    Alizadeh Dehnavi R; Beishuizen ED; van de Ree MA; Le Cessie S; Huisman MV; Kluft C; Princen HM; Tamsma JT
    Eur J Intern Med; 2008 Mar; 19(2):115-21. PubMed ID: 18249307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.